Shayne Ladak, MD

New Mexico
Shayne Ladak, MD
Vascular Parkinsonism: A Clinical Overview for Palliative Healthcare Providers

Vascular Parkinsonism: A Clinical Overview for Palliative Healthcare Providers

Introduction Parkinsonism, defined by bradykinesia, rigidity, resting tremor, and postural instability, is most commonly attributed to idiopathic Parkinson’s disease (PD). However, not all patients with parkinsonian features have classic PD. A notable subset, particularly among older adults with vascular risk factors, develops parkinsonism due to cerebrovascular disease. This condition,

By Shayne Ladak, MD
The Role of Palliative Care in Chronic Illnesses: Improving Quality of Life for Patients with Cancer, Heart Failure, and COPD

The Role of Palliative Care in Chronic Illnesses: Improving Quality of Life for Patients with Cancer, Heart Failure, and COPD

Chronic illnesses, such as cancer, heart failure, and chronic obstructive pulmonary disease (COPD), present significant challenges not only for patients but also for their families and healthcare providers. These conditions often require ongoing medical treatment and management, leading to symptoms that are not only physically debilitating but also emotionally and

By Shayne Ladak, MD
Educating Patients and Families on the Benefits of Palliative Care: A Guide for Healthcare Professionals

Educating Patients and Families on the Benefits of Palliative Care: A Guide for Healthcare Professionals

Chronic illnesses such as cancer, heart failure, and chronic obstructive pulmonary disease (COPD) are life-altering diagnoses that bring not only physical symptoms, but also emotional, psychological, and spiritual challenges. While curative and life-prolonging treatments are often prioritized in care plans, a powerful and often underutilized complement—or alternative—is palliative

By Shayne Ladak, MD
The Role of Ritalin in Severe Depression in the Palliative Setting: A Rapid-Acting Option When Time Matters

The Role of Ritalin in Severe Depression in the Palliative Setting: A Rapid-Acting Option When Time Matters

When we think of antidepressants, our minds often drift to selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclics (TCAs), or even atypical agents like mirtazapine or bupropion. These medications, while effective in the general population, are limited by their delayed onset — often taking weeks to manifest meaningful clinical

By Shayne Ladak, MD